市場調査レポート

商品コード

1593489

がん登録ソフトウェアの市場規模・シェア・成長分析 (種類別、展開モデル別、データベース別、機能別、エンドユーザー別、地域別)：産業予測 (2024～2031年)

Cancer Registry Software Market Size, Share, Growth Analysis, By Type (Standalone Software, Integrated Software), By Deployment Model (On-premises and Cloud-based), By Database, By Functionality, By End User, By Region - Industry Forecast 2024-2031.

出版日: 2024年11月09日
発行: SkyQuest
ページ情報: 英文 166 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 789,170円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 923,180円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,057,190円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.90円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のがん登録ソフトウェアの市場規模は、2023年に7,067万米ドルとなり、2024年の7,809万米ドルから2031年には1億7,358万米ドルに成長し、予測期間 (2024～2031年) に10.5%のCAGRで成長する見込みです。

がん登録ソフトウェア市場は、効果的ながん管理、医療の質向上、コスト削減に対する需要の高まりによって大きな成長を遂げています。この高度なデータベースシステムは、治療成果を評価するための患者データの整理・収集・保存に重要な役割を果たし、それが情報管理の改善とがん登録データへのアクセスを促進します。市場サーベイランスのためのがん患者登録データの利用が増加し、電子カルテ (EHR) の普及がこの成長をさらに後押ししています。さらに、最近の製品の承認や発売も市場拡大に寄与しています。ワークフローの最適化と医師の負担軽減に対する需要は、医療環境における高度なソフトウェア・ソリューションの統合を大幅に促進しています。政府の公衆衛生への注力、医療インフラへの投資、医療費上昇の抑制を目的としたイニシアチブなどが、市場の加速的発展に関連しています。このがん登録ソリューションの主な利点 (合理化されたワークフロー、自動化された症例登録、がん症例の増加など) が、その採用を促進すると予想されます。さらに、さまざまな政府機関ががん登録の確立を積極的に推進しており、これが市場の成長を促進すると思われます。予測期間中、これらの要因が組み合わさることで、がん登録ソフトウェア市場は堅調な軌道を描き、現代の医療管理戦略に不可欠なコンポーネントとして位置づけられます。

北米 (種類別、展開モデル別、データベース別、機能別、エンドユーザー別)
- 米国
- カナダ
欧州 (種類別、展開モデル別、データベース別、機能別、エンドユーザー別)
- 英国
- ドイツ
- スペイン
- フランス
- イタリア
- その他欧州
アジア太平洋 (種類別、展開モデル別、データベース別、機能別、エンドユーザー別)
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ (種類別、展開モデル別、データベース別、機能別、エンドユーザー別)
- ブラジル
- その他ラテンアメリカ
中東・アフリカ (種類別、展開モデル別、データベース別、機能別、エンドユーザー別)
- 湾岸協力会議 (GCC) 諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング (2023年)
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析 (2023年)
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の対前年成長率 (YoY) の比較 (2021～2023年)

主要企業プロファイル

IBM Watson Health
Oracle Corporation
Siemens Healthineers
Cerner Corporation
Epic Systems Corporation
MEDITECH
Allscripts Healthcare Solutions
McKesson Corporation
Philips Healthcare
GE Healthcare
Inova Health System
Varian Medical Systems
Roche Diagnostics
TomoTherapy Inc.
Health Information Systems
Elekta
ONCO, Inc.
Conduent, Inc.
Ordinate Corporation
Volpara Health Limited

結論と推奨事項

Product Code: SQMIG35G2301

Global Cancer Registry Software Market size was valued at USD 70.67 Million in 2023 poised to grow from USD 78.09 Million in 2024 to USD 173.58 Million by 2031, growing at a CAGR of 10.5% in the forecast period (2024-2031).

The cancer registry software market is experiencing significant growth driven by the increasing demand for effective cancer management, enhanced healthcare quality, and reduced costs. This sophisticated database system plays a crucial role in organizing, collecting, and preserving patient data to evaluate treatment outcomes, thus fostering better information management and access to cancer registry data. The rise in the utilization of cancer patient registry data for market surveillance and the widespread adoption of Electronic Health Records (EHRs) further fuel this growth. Additionally, recent product approvals and launches contribute to market expansion. The demand for optimized workflows and the alleviation of physician workloads are substantially driving the integration of advanced software solutions in healthcare settings. Factors such as governmental focus on population health, investments in healthcare infrastructure, and initiatives aimed at controlling rising healthcare expenses correlate with an accelerated development of the market. Key benefits of these cancer registry solutions, including streamlined workflows, automated case registries, and the increase in cancer cases, are anticipated to bolster their adoption. Moreover, various governmental organizations are actively promoting the establishment of cancer registries, which is likely to expedite market growth. As we move through the projection period, the combination of these factors suggests a robust trajectory for the cancer registry software market, positioning it as an essential component of modern healthcare management strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cancer Registry Software market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cancer Registry Software Market Segmental Analysis

Global Cancer Registry Software Market is segmented by Type, Deployment Model, Database, Functionality, end user and region. Based on Type, the market is segmented into Standalone Software, Integrated Software. Based on Deployment Model, the market is segmented into On-premises, Cloud-based. Based on Database, the market is segmented into Commercial Databases, Public Databases. Based on Functionality, the market is segmented into Cancer Reporting to Meet State & Federal Regulations, Patient Care Management, Product Outcome Evaluation, Medical Research and Clinical Studies. Based on end user, the market is segmented into Government Organizations & Third-party Administrators (TPAS), Hospitals & Medical Practices, Pharmaceutical, Biotechnology, & Medical Device Companies, Private Payers, Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cancer Registry Software Market

The increasing focus on enhancing population health management and the efficient exchange of health information is a significant market driver for the Global Cancer Registry Software market. Governments worldwide are actively promoting the establishment of cancer registries to combat rising cancer incidence rates, with many agencies investing in digitization initiatives and the development of computerized illness registries. By facilitating real-time data collection and analysis, these software solutions enable better management of cancer care, resource allocation, and targeted public health strategies. As a result, the push for improved governmental healthcare systems is fueling demand for advanced cancer registry software solutions.

Restraints in the Global Cancer Registry Software Market

One of the significant market restraints for the Global Cancer Registry Software market is the increasing concern over data privacy and security. With family member information often intertwined with patient health data, the risk of data breaches poses a critical threat to confidentiality. Such incidents can lead to sensitive information falling into unauthorized hands, raising ethical and legal implications. Governments in developed economies are struggling to establish regulations that adequately protect privacy while promoting data accessibility for research and healthcare improvement. This regulatory uncertainty can slow software adoption and deter potential investments, thus hindering market growth in the cancer registry sector.

Market Trends of the Global Cancer Registry Software Market

The global cancer registry software market is witnessing a robust trend towards comprehensive data management coupled with increased global adoption, driven by the escalating need for precise cancer analytics in healthcare systems. Hospitals are increasingly integrating advanced registry software solutions to streamline the collection, processing, and organization of cancer-related patient data. This shift enhances the quality of oncology care, enabling healthcare providers to glean insights for better treatment protocols and resource allocation. Moreover, rising awareness of cancer epidemiology, coupled with regulatory support for cancer data reporting, is substantially propelling the demand for efficient and adaptable cancer registry systems worldwide.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Case Study Analysis
PESTEL Analysis
Macro-Economic Indicators

Global Cancer Registry Software Market Size by Type & CAGR (2024-2031)

Market Overview
Standalone Software
Integrated Software

Global Cancer Registry Software Market Size by Deployment Model & CAGR (2024-2031)

Market Overview
On-premises
Cloud-based

Global Cancer Registry Software Market Size by Database & CAGR (2024-2031)

Market Overview
Commercial Databases
Public Databases

Global Cancer Registry Software Market Size by Functionality & CAGR (2024-2031)

Market Overview
Cancer Reporting to Meet State & Federal Regulations
Patient Care Management
Product Outcome Evaluation
Medical Research and Clinical Studies

Global Cancer Registry Software Market Size by End-User & CAGR (2024-2031)

Market Overview
Government Organizations & Third-party Administrators (TPAS)
Hospitals & Medical Practices
Pharmaceutical, Biotechnology, & Medical Device Companies
Private Payers
Research Centers

Global Cancer Registry Software Market Size & CAGR (2024-2031)

North America, (Type, Deployment Model, Database, Functionality, End-User)
- US
- Canada
Europe, (Type, Deployment Model, Database, Functionality, End-User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Type, Deployment Model, Database, Functionality, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Type, Deployment Model, Database, Functionality, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Type, Deployment Model, Database, Functionality, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

IBM Watson Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oracle Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cerner Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Epic Systems Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MEDITECH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allscripts Healthcare Solutions
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
McKesson Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inova Health System
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Varian Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TomoTherapy Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Health Information Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elekta
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ONCO, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conduent, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ordinate Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Volpara Health Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

がん登録ソフトウェアの市場規模・シェア・成長分析 (種類別、展開モデル別、データベース別、機能別、エンドユーザー別、地域別)：産業予測 (2024～2031年)

Cancer Registry Software Market Size, Share, Growth Analysis, By Type (Standalone Software, Integrated Software), By Deployment Model (On-premises and Cloud-based), By Database, By Functionality, By End User, By Region - Industry Forecast 2024-2031.

目次

イントロダクション

分析手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

世界のがん登録ソフトウェアの市場規模 (種類別)・CAGR (2024～2031年)

世界のがん登録ソフトウェアの市場規模 (展開モデル別)・CAGR (2024～2031年)

世界のがん登録ソフトウェアの市場規模 (データベース別)・CAGR (2024～2031年)

世界のがん登録ソフトウェアの市場規模 (機能別)・CAGR (2024～2031年)

世界のがん登録ソフトウェアの市場規模 (エンドユーザー別)・CAGR (2024～2031年)

世界のがん登録ソフトウェアの市場規模・CAGR (2024～2031年)